Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Ardelyx licenses NaPi-2b phosphate inhibitor program to Sanofi

Feb. 25, 2014

Dosing completed in phase II trial of GCS-100 for chronic kidney disease

Feb. 24, 2014

Regulus Therapeutics nominates RG-012 as candidate for Alport syndrome

Feb. 21, 2014

Japanese researchers claim new prostanoid EP1 receptor antagonists

Feb. 17, 2014

Astellas reports melatonin agonists for urinary incontinence

Jan. 29, 2014

Japan Tobacco and Torii gain approval for Riona Tablets in Japan

Jan. 17, 2014

Extended treatment phase of ZS-9 phase III trial in hyperkalemia meets endpoint

Jan. 15, 2014

Proteon obtains E.U. orphan drug status for PRT-201 for hemodialysis vascular access

Jan. 10, 2014

Development and characterization of an orally available antifibrotic drug to treat renal fibrosis

Jan. 2, 2014

Novel autotaxin inhibitors synthesized by Roche

Dec. 31, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...